4/BA.5-adapted bivalent COVID-19 vaccine for children aged 5 through 11 years old has been made by BioNTech and Pfizer, it emerged yesterday. With a corresponding application for extension of ...

The news follows the recent recommendation of the human medicines committee (CHMP) of the European Medicine Agency (EMA) to authorise COVID-19 bivalent vaccines from both Pfizer/BioNTech and Moderna.

While short-term side effects are slightly worse with Moderna than with Pfizer, Moderna kids appear to gain protection against COVID in a matter of weeks, not months. Moderna's vaccine for babies ...

US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years ...

Brazil's National Health Surveillance Agency (Anvisa) has received a request for the emergency use of Pfizer's newest vaccine ... to combat Omicron. The bivalent vaccine, manufactured by US ...